Through-the-scope esophageal stent for the relief of malignant dysphagia: Results of a multicentric study (with video).
malignant dysphagia
self-expandable metal stent
through-the-scope esophageal stent
Journal
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
ISSN: 1443-1661
Titre abrégé: Dig Endosc
Pays: Australia
ID NLM: 9101419
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
15
01
2020
revised:
01
04
2020
accepted:
20
04
2020
pubmed:
26
4
2020
medline:
29
7
2021
entrez:
26
4
2020
Statut:
ppublish
Résumé
In presence of malignant dysphagia, in patients unfit for surgery, the placement of a self-expandable metal stent (SEMS) represents a safe and effective palliative treatment. Esophageal stents (ES) present an over-the-wire mechanism where the stent is deployed under X-ray control. Recently a through-the-scope (TTS) ES was launched. The aim of our retrospective study is to assess the technical and clinical success of the new TTS-ES. Patients with malignant dysphagia caused by esophageal cancer or ab-extrinsic compression, who underwent TTS esophageal stent in six Italian endoscopic referral centers, were retrospectively reviewed. A total of 40 patients were enrolled. TTS stent placement was successful in 39/40 patients (97.5%). 31 patients had an Ogilvie score of 4, nine an Ogilvie 3. After 2 weeks from stent placement 29 reported Ogilvie score of 0, eight a score of 1. None of the patients developed retrosternal pain requiring drugs. No patient experienced perforation, bleeding or migration. A total of seven patients (18%) developed dysphagia as late adverse event (AE). Through-the-scope ES presented less AEs, in terms of bleeding and perforation, if compared to the previous published data. An anti-migration system could be helpful, especially when the stent is placed for "ab-extrinseco" malignant dysphagia.
Sections du résumé
BACKGROUND AND AIM
OBJECTIVE
In presence of malignant dysphagia, in patients unfit for surgery, the placement of a self-expandable metal stent (SEMS) represents a safe and effective palliative treatment. Esophageal stents (ES) present an over-the-wire mechanism where the stent is deployed under X-ray control. Recently a through-the-scope (TTS) ES was launched. The aim of our retrospective study is to assess the technical and clinical success of the new TTS-ES.
MATERIALS AND METHODS
METHODS
Patients with malignant dysphagia caused by esophageal cancer or ab-extrinsic compression, who underwent TTS esophageal stent in six Italian endoscopic referral centers, were retrospectively reviewed.
RESULTS
RESULTS
A total of 40 patients were enrolled. TTS stent placement was successful in 39/40 patients (97.5%). 31 patients had an Ogilvie score of 4, nine an Ogilvie 3. After 2 weeks from stent placement 29 reported Ogilvie score of 0, eight a score of 1. None of the patients developed retrosternal pain requiring drugs. No patient experienced perforation, bleeding or migration. A total of seven patients (18%) developed dysphagia as late adverse event (AE).
CONCLUSION
CONCLUSIONS
Through-the-scope ES presented less AEs, in terms of bleeding and perforation, if compared to the previous published data. An anti-migration system could be helpful, especially when the stent is placed for "ab-extrinseco" malignant dysphagia.
Types de publication
Journal Article
Multicenter Study
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Pagination
118-124Informations de copyright
© 2020 Japan Gastroenterological Endoscopy Society.
Références
Short MW, Burgers KG, Fry VT. Esophageal cancer. Am Fam Physician 2017; 95: 22-8.
van der Bogt RD, Vermeulen BD, Reijm AN et al. Palliation of dysphagia. Best Pract Res Clin Gastroenterol 2018; 36-37: 97-103.
Spaander MC, Baron TH, Siersema PD et alEsophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 2016; 48: 939-48.
Adler DG. Esophageal stents: Placement, complications, tips, and tricks. Video Journal and Encyclopedia of GI Endoscopy 2013; 1: 66-8.
Ogilvie AL, Dronfield MW, Ferguson R et al.Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut 1982; 23: 1060-7.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al.Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-403.
Van Heel NC, Haringsma J, Spaander MC et al.Esophageal stents for the palliation of malignant dysphagia and fistula recurrence after esophagectomy. Gastrointest Endosc 2010; 72: 249-54.
van Heel NC, Haringsma J, Spaander MC et al.Esophageal stents for the relief of malignant dysphagia due to extrinsic compression. Endoscopy 2010; 42: 536-40.
Homs MY, Steyerberg EW, Eijkenboom WM et al.Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: Multicentre randomised trial. Lancet 2004; 364: 1497-504.
Repici A, Jovani M, Hassan C et al.Management of inoperable malignant oesophageal strictures with fully covered WallFlex(®) stent: A multicentre prospective study. Dig Liver Dis 2014; 46: 1093-8.
Hirdes MM, Siersema PD, Vleggaar FP. A new fully covered metal stent for the treatment of benign and malignant dysphagia: A prospective follow-up study. Gastrointest Endosc 2012; 75: 712-8.
Walter D, van den Berg MW, van Hooft JE et al.A new fully covered metal stent with anti-migration features for the treatment of malignant dysphagia. Endoscopy 2014; 46: 1101-5.
Didden P, Reijm AN, Erler NS et al.Fully vs. partially covered self-expandable metal stent for palliation of malignant esophageal strictures: A randomized trial (the COPAC study). Endoscopy 2018; 50: 961-71.
Persson J, Smedh U, Johnsson Å et al.Fully covered stents are similar to semi-covered stents with regard to migration in palliative treatment of malignant strictures of the esophagus and gastric cardia: Results of a randomized controlled trial. Surg Endosc 2017; 31: 4025-33.
Vermeulen BD, Reijm AN, van der Bogt RD et al.Through-the-scope placement of a fully covered metal stent for palliation of malignant dysphagia: A prospective cohort study (with video). Gastrointest Endosc 2019; 90: 972-9.